Literature DB >> 8489322

Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

A J Zametkin1, L L Liebenauer, G A Fitzgerald, A C King, D V Minkunas, P Herscovitch, E M Yamada, R M Cohen.   

Abstract

OBJECTIVES: We sought to obtain and compare values of cerebral glucose metabolism in normal minors and minors with Attention Deficit Hyperactivity Disorder (ADHD). We also sought to confirm our earlier findings of reduced brain metabolism in adults with ADHD, and to examine whether these results might be diagnostically useful.
DESIGN: Case-control study.
SETTING: Adolescents were recruited to National Institutes of Health Clinical Center/Research Facility through advertisement at local high schools and ADHD organizations. PATIENTS: Subjects were 10 normal adolescents and 10 adolescents with ADHD diagnosed with structured interviews using DSM-III-R criteria. MAIN OUTCOME MEASURES: Positron emission tomography and fludeoxyglucose F18 were used to study cerebral glucose metabolism in minors while they performed an auditory-attention task.
RESULTS: Global or absolute measures of metabolism did not statistically differ between groups, although hyperactive girls had a 17.6% lower absolute brain metabolism than normal girls. As compared with the values for the controls, normalized glucose metabolism was significantly reduced in six of 60 specific regions of the brain, including an area of the left anterior frontal lobe (P < .05). Lower metabolism in that specific region of the left anterior frontal lobe was significantly inversely correlated with measures of symptom severity (P < .001-.009, r = -.56 to -.67).
CONCLUSIONS: Global or absolute measures of metabolism using positron emission tomography and fludeoxyglucose F18 did not statistically differentiate between normal adolescents with ADHD. Positron emission tomography scans can be performed and are well tolerated by normal teenagers and teenagers with ADHD. The feasibility of normal minors participating in research involving radiation was established.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489322     DOI: 10.1001/archpsyc.1993.01820170011002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  27 in total

Review 1.  Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels?

Authors:  Dieter Baeyens; Herbert Roeyers; Johan Vande Walle
Journal:  Child Psychiatry Hum Dev       Date:  2006

Review 2.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 3.  [Functional imaging of neurocognitive dysfunction in attention deficit hyperactivity disorder].

Authors:  I Wolf; H Tost; M Ruf; M H Schmidt; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

4.  Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder.

Authors:  Boong-Nyun Kim; Jae-Won Kim; Hyejin Kang; Soo-Churl Cho; Min-Sup Shin; Hee-Jeong Yoo; Soon-Beom Hong; Dong Soo Lee
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

Review 5.  Utilization behavior: clinical manifestations and neurological mechanisms.

Authors:  S J Archibald; C A Mateer; K A Kerns
Journal:  Neuropsychol Rev       Date:  2001-09       Impact factor: 7.444

6.  Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.

Authors:  Justin M Drerup; Kanehiro Hayashi; Huxing Cui; Gabriel L Mettlach; Michael A Long; Marian Marvin; Xiankai Sun; Matthew S Goldberg; Michael Lutter; James A Bibb
Journal:  Biol Psychiatry       Date:  2010-09-15       Impact factor: 13.382

7.  ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD.

Authors:  T Sigi Hale; Susan L Smalley; Jeff Dang; Grant Hanada; James Macion; James T McCracken; James J McGough; Sandra K Loo
Journal:  J Psychiatr Res       Date:  2009-12-16       Impact factor: 4.791

8.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation.

Authors:  P Shaw; K Eckstrand; W Sharp; J Blumenthal; J P Lerch; D Greenstein; L Clasen; A Evans; J Giedd; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.